Do larger breasts increase breast cancer risk? What experts really say
It is a question often asked but rarely answered clearly: does having larger breasts increase your risk of breast cancer?
As breast cancer cases in young Aussie women increase at a concerning rate, this question has never been more pressing.
According to leading breast cancer surgeon and researcher Dr Sanjay Warrier, the answer is more nuanced than a simple yes or no.
'Breast size in itself is not considered a direct or independent risk factor for breast cancer,' Professor Warrier told news.com.au.
'The assumption that larger breasts may increase risk lacks strong clinical evidence and is not supported by robust data.'
However, he urges women with larger breasts to still be proactive about their health, especially if they have other contributing risk factors such as a family history of breast cancer, a sedentary lifestyle, or hormonal influences.
Breast density a more important factor
More importantly, breast tissue composition, specifically breast density, plays a far more significant role in breast cancer risk than size alone, Prof Warrier said.
The BI-RADS (Breast Imaging Reporting and Data System) density scale is used to classify breast tissue, with categories C and D indicating higher density.
Women with smaller breasts can still have high breast density, which is why it's important to check the scale.
High-density breast tissue is associated with a slightly increased risk of cancer and can make tumours more difficult to detect on standard mammograms, as dense tissue appears white on imaging, which is the same colour as potential tumours.
For women with larger breasts, tumours may also be more difficult to detect, sometimes leading to delayed diagnosis.
In these cases, contrast-enhanced mammography or a MRI is often recommended for improved clarity.
Other factors to consider
Prof Warrier also highlighted that women with a higher Body Mass Index (BMI), which may correlate with larger breast size, are at a statistically higher risk of developing breast cancer, especially after menopause.
'Higher body weight means more fat tissue, which in turn increases oestrogen levels, leading to a higher risk of hormone receptor-positive breast cancers,' he said.
'Hormonal exposure across a woman's lifespan, including early menarche, late menopause, and hormone replacement therapy, also elevates risk by increasing the duration of oestrogen exposure.'
A preventive approach
The key takeaway is that breast size alone does not determine your cancer risk.
It's the broader picture of lifestyle, hormonal exposure, weight, family history, and breast density that matters.
Prof Warrier advises women of all body types to adopt a preventive approach to breast health, incorporating self-examinations, regular screenings, a wholefood diet, physical activity, and limiting alcohol and processed food intake.
Taking a personalised approach to breast cancer screening is also increasingly regarded as best practice.
New research proves promising
While standard population-based screening generally begins at age 50, emerging evidence suggests that earlier and more frequent screening may benefit those at higher risk.
Landmark studies such as the PROCAS trial in the UK and the ROSA Project in Victoria are exploring risk-based models that take these variables into account.
These studies are helping to shape new guidelines for tailored screening strategies.
This may not only lead to earlier detection but also reduce the need for aggressive treatments and improve overall outcomes by catching cancers at a more manageable stage.
Breast cancer diagnoses on the rise
It comes as breast cancer diagnoses continue to rise among young women in Australia.
Breast cancer is estimated to be the most commonly diagnosed cancer in women aged 20-39, and every day around three women under 40 are diagnosed with breast cancer.
Breast cancers in young women tend to have different characteristics and poorer survival outcomes compared with older women, making early detection vital.
If you have concerns about your breast cancer risk, make an appointment with your GP to discuss your personal situation and the best screening options for you.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

News.com.au
4 hours ago
- News.com.au
Coles recalls two peanut butter products sold in the past two months over toxin contamination
Coles has issued a major product recall after two of its home-brand peanut butter products were found to be contaminated with a toxin. Coles Smooth Peanut Butter 1kg and Coles Crunchy Peanut Butter 1kg jars sold between the of May and June this year have been recalled nationally due to aflatoxin contamination. Aflatoxin is a biotoxin that can cause injury or illness if consumed. It comes from a family of toxins that is found on crops including corn and peanuts. Exposure to aflatoxins has been associated with an increased risk of liver cancer. Food Standards has warned consumers not to eat the product and to return it to their place of purchase. Customers should beware of any product with the best before date of 5 February 2027. Anyone concerned about their health should seek medical advice. Anyone who bought the peanut butter products can return the jars to any Coles supermarket for a full refund, online customers can contact Coles Online Customer Care. Coles apologised to customers 'for any inconvenience'.

News.com.au
5 hours ago
- News.com.au
Closing Bell: Healthcare sector gives ASX a booster to rise 0.33pc
ASX lifts 0.33pc on healthcare sector strength CSL adds 2.4pc as UBS marks ASX healthcare sector as best EPS pick Chinese manufacturing data contracts, but shows signs of stirring Are healthcare bulls returning? The ASX healthcare sector was the best performing of the ASX's 11 subcategories in trade today, handily outperforming the other sectors with a 1.58% jump. With support from industrials (+1%) and consumer discretionary (+0.98%), that was enough for the ASX 200 to make a convincing gain of 0.33% today, having had a steady run of momentum throughout trade. Regis Healthcare (ASX:REG) added 3.2%, Ramsay Health Care (ASX:RHC) 1.9% and Summerset Group (ASX:SNZ) 1.3%. As for our healthcare giants, CSL (ASX:CSL) gained 2.4%, Pro Medicus (ASX:PME) 2% and Cochlear (ASX:COH) 1.7%. If financial giant UBS is to be believed, this may be the start of a bit of a bullish run for ASX biotech stocks, which have been suffering over the past few months. UBS reckons the ASX healthcare sector is now undervalued, offering the best earnings-per-share growth of all sectors, and forecasting a 20% increase in the 2025-26 year. 'Investor sentiment towards the healthcare sector has broadly cooled over the past year, with some marked deterioration seen across many stocks,' UBS says. 'Cochlear in particular has seen investor apathy build over the last year, which represents a significant change of views.' Back on the ASX today, the main drag was in the materials sector, down 0.77%. The ASX 200 Resources index was also an anchor, shedding 0.96%, but it was outweighed by gains in the All Tech, Gold and Small Ords indices. Chinese manufacturing data contracts again While iron ore has been enjoying a small uptick in pricing the past five days or so, the latest data out of China isn't the best news for Aussie base metal stocks. Manufacturing activity from our largest trading partner fell again for a third month straight in June, despite Beijing's attempts to stimulate the sector. The official purchasing manager's index did improve slightly from 49.5 in May to 49.7 in June, but remained below the 50-point benchmark which indicates whether the index is expanding or contracting. Inventory and employment levels at factories fell as well, but the news wasn't all bad. The sub-index tracking manufacturing production rose to 51 and new orders lifted to 50.2, which could indicate the first stirrings of momentum beginning to build in China's industrial activity. Chinese Premier Li Qiang said Chinese authorities would implement measures to 'make China a mega-sized consumption powerhouse' as well as a manufacturing one in a speech at the World Economic Forum's annual conference in China. 'We still think that there are challenges this year, but I think it's not as far-fetched as we thought before,' Oxford Economics lead economist for China Louise Loo said. 'However punitive tariffs are, I think in the near term, it's quite hard to decouple China from global supply chains, and that means we will continue to see China exports, at least, remain quite competitive, and that should support economic growth for the Chinese.' It remains to be seen if that will translate into higher demand for Australian iron ore, but one can hope. ASX SMALL CAP LEADERS Today's best performing small cap stocks: Security Name Last % Change Volume Market Cap WEL Winchester Energy 0.002 100% 165600 $1,363,019 LSR Lodestar Minerals 0.011 83% 42455380 $1,910,543 ADD Adavale Resource Ltd 0.0015 50% 15489651 $2,287,279 ADY Admiralty Resources. 0.006 50% 1690337 $10,517,918 EEL Enrg Elements Ltd 0.0015 50% 860601 $3,253,779 MPR Mpower Group Limited 0.01 43% 5225088 $2,405,923 GTE Great Western Exp. 0.011 38% 3625782 $4,542,063 MEG Megado Minerals Ltd 0.023 35% 4786016 $10,313,615 ALM Alma Metals Ltd 0.004 33% 2325000 $5,261,182 FCT Firstwave Cloud Tech 0.016 33% 3070713 $20,562,224 FHS Freehill Mining Ltd. 0.004 33% 15028446 $10,241,561 GTR Gti Energy Ltd 0.004 33% 5538733 $8,996,849 SPX Spenda Limited 0.008 33% 16838995 $27,691,293 GLH Global Health Ltd 0.068 33% 176778 $2,987,301 AAU Antilles Gold Ltd 0.005 25% 6046776 $9,516,272 ERL Empire Resources 0.005 25% 692641 $5,935,653 RCM Rapid Critical 0.0025 25% 1125000 $2,831,556 ROG Red Sky Energy. 0.005 25% 120000 $21,688,909 TMX Terrain Minerals 0.0025 25% 5339766 $5,063,629 VR1 Vection Technologies 0.036 24% 40421798 $51,255,235 THR Thor Energy PLC 0.011 22% 2677843 $6,397,109 KNB Koonenberrygold 0.039 22% 46537381 $32,790,159 RPG Raptis Group Limited 0.063 21% 185561 $18,235,612 NGX Ngxlimited 0.145 21% 45773 $10,873,421 SDV Scidev Ltd 0.36 20% 293999 $57,026,459 Making news… Lodestar Minerals (ASX:LSR) is looking to follow up on gold hits at its Chilean copper-gold projects with proceeds from a $2.2m two-tranche share placement. LSR is offering $475k in the first tranche to clients of lead manager Oakley Capital Partners, with the rest hanging on shareholder approval. Adavale Resources (ASX:ADD) is preparing to put drill bit to ground at the London Victoria Mine in NSW, which historically produced gold grades up to 43.8 g/t gold. It's the first exploration at the mine in 30 years; ADD will target shallow extensions to the existing mineral resource estimate, which currently sits at 115,000 ounces of gold. FirstWave Cloud Technology (ASX:FCT) has inked a licensing agreement with Claro Dominican Republic to license its NMIS v9 network management software suite for an upfront fee of US$250k. It's a pure-profit contract, as the contract doesn't require delivery, support or professional services. GTI Energy (ASX:GTR) is locking in a $4.5m placement at an issue price of 0.035 cents a share, a 16.7% premium to the last close price of 0.030 cents. The money will be funnelled directly to resource expansion and infill drilling at the Lo Herma uranium project. GTR's recent scoping study revealed a potential pre-tax net present value of between $174m and $187m and an internal rate of return of between 52% and 66% for Lo Herma. Check out Stockhead's Break it Down for more on GTR's capital raising. Spenda (ASX:SPX) has teamed up with APG Pay Pty Ltd to develop and commercialise a corporate credit platform. The two companies will collab on a scaleable B2B payments space that can scale across multiple industries, starting with the travel industry. Spenda reckons the deal will bring in recurring profit of $1.7m per year. ASX SMALL CAP LAGGARDS Today's worst performing small cap stocks: Security Name Last % Change Volume Market Cap CT1 Constellation Tech 0.001 -50% 1322698 $2,949,467 IS3 I Synergy Group Ltd 0.002 -50% 3892995 $2,002,920 T3D 333D Limited 0.006 -33% 33333 $1,585,651 ADR Adherium Ltd 0.004 -33% 3436600 $5,390,874 TEG Triangle Energy Ltd 0.002 -33% 4164703 $6,267,702 TKL Traka Resources 0.001 -33% 135263 $3,188,685 L1M Lightning Minerals 0.043 -28% 1471249 $6,199,699 ZMM Zimi Ltd 0.008 -27% 616731 $4,702,982 FIN FIN Resources Ltd 0.003 -25% 557800 $2,779,554 GMN Gold Mountain Ltd 0.0015 -25% 1983598 $11,239,518 HLX Helix Resources 0.0015 -25% 1234287 $6,728,387 SFG Seafarms Group Ltd 0.0015 -25% 893383 $9,673,198 SRN Surefire Rescs NL 0.0015 -25% 334051 $4,972,891 TYX Tyranna Res Ltd 0.003 -25% 325000 $13,153,701 GLA Gladiator Resources 0.007 -22% 1626499 $6,824,671 YAR Yari Minerals Ltd 0.012 -20% 2978290 $8,320,672 AUK Aumake Limited 0.002 -20% 1177734 $7,558,397 MEM Memphasys Ltd 0.004 -20% 6329063 $9,917,991 MKL Mighty Kingdom Ltd 0.016 -20% 1737419 $10,326,928 PPG Pro-Pac Packaging 0.016 -20% 78233 $3,633,754 RAN Range International 0.002 -20% 2187661 $2,348,226 SKK Stakk Limited 0.004 -20% 2620995 $10,375,398 VEN Vintage Energy 0.004 -20% 1780465 $10,434,568 HIQ Hitiq Limited 0.014 -18% 1054211 $7,814,865 BDM Burgundy D Mines Ltd 0.029 -17% 604995 $49,746,630 IN CASE YOU MISSED IT QPM Energy (ASX:QPM) is powering up with plans for a new gas-fired plant at the Isaac Energy Hub. Astute Metals (ASX:ASE) has identified four high-priority gold-silver targets at its Needles project in Nevada, USA, thanks to a data review. Green Critical Minerals (ASX:GCM) has cleared another hurdle at the McIntosh graphite project with a PFS showcasing robust economics including $25m post-tax NPV, 25.3% IRR and a 32.5-year mine life. LTR Pharma (ASX:LTP) has completed extractables studies for its Spontan intranasal spray for erectile dysfunction and kicked off a leachables study. Ausgold (ASX:AUC) has released a positive definitive feasibility study for its Katanning gold project (KGP) in WA, highlighting robust returns over a 10-year mine life. Theta Gold Mines' (ASX:TGM) board has rubber stamped the TGME mine in South Africa's Mpumalanga region as high gold prices stir investment in the historic mining district. Break it Down: Anson Resources (ASX:ASN) has paired up with a Korean battery maker to develop a DLE demonstration plant at the Green River project in Utah. Redcastle Resources (ASX:RC1) is on its way to becoming an integrated exploration and production company after lifting resources to 42,000oz at the Redcastle project. TRADING HALTS Australian Mines (ASX:AUZ) – cap raise and potential acquisition AuKing Mining (ASX:AKN) – cap raise Battery Age Minerals (ASX:BM8) – cap raise Blackstone Minerals (ASX:BSX) – cap raise archTIS (ASX:AR9) – cap raise Lodestar Minerals (ASX:LSR) – cap raise Liontown Resources (ASX:LTR) – executive changes Olympio Metals (ASX:OLY) – cap raise Peak Minerals (ASX:PUA) – response to ASX price query Red Mountain Mining (ASX:RMX) – cap raise (ASX:RNT) – cap raise Terra Uranium (ASX:T92) – acquisition and cap raise Vitasora Health (ASX:VHL) – cap raise At Stockhead, we tell it like it is. While GTI Energy is a Stockhead advertiser, it did not sponsor this article.

News.com.au
5 hours ago
- News.com.au
Health alert has been issued in Sydney after an infectious measles patient visited several spots across the city
NSW Health has issued a warning after an infectious measles patient visited a cafe and emergency department in Sydney. The infectious person, who recently returned from measles hotspot Vietnam, visited Sir Reuben cafe in Rozelle and the Concord Hospital Emergency Department. Authorities have warned anyone who visited the cafe between 12pm and 1pm on Sunday, June 22 and anyone who attended the emergency department between 10.35pm and 3.10am on Saturday, June 28 to be on alert for any symptoms. There is no ongoing risk at the two locations. Sydney Local Health District Director of Public Health Dr Leena Gupta urged people to be on alert. 'Measles is a vaccine preventable disease that is spread through the air when someone who is infectious coughs or sneezes,' Dr Gupta said. 'Symptoms to watch out for include fever, runny nose, sore eyes and a cough, usually followed three or four days later by a red, blotchy rash that spreads from the head to the rest of the body. 'It can take up to 18 days for symptoms to appear after an exposure, so it's important for people who visited these locations to look out for symptoms up until 18 July.' She said that anyone who develops symptoms should call their GP or emergency department before attending to ensure they do not spread the disease to other patients while waiting. 'We want to remind the community to make sure they are up to date with their vaccinations. The measles vaccine can prevent the disease even after exposure, if given early enough,' Dr Gupta said. 'Anyone born after 1965 needs to ensure they have had two doses of measles vaccine. This is especially important before overseas travel, as measles outbreaks are occurring in several regions of the world at the moment.' Measles cases have been popping up across the country, with Australia recording its highest number of cases in six years.